Richard Edlin

Track

Insider profile

Currently holds a position at Eagle Pharmaceuticals Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Eagle Pharmaceuticals Inc March 17, 2017 -
Richard Edlin's trades of Eagle Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
447.19
Quantity 89,891 -49.5%
Value US$1,358,986
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-08 2022-09-06
S Sale
89,891 -49.5%
447.19
US$1,358,986 		89,891 -49.5% 447.19 US$1,358,986